Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease
- Authors
- Moon, Seong Mi; Kim, Su-Young; Kim, Dae Hun; Huh, Hee Jae; Lee, Nam Yong; Jhun, Byung Woo
- Issue Date
- 19-Apr-2022
- Publisher
- AMER SOC MICROBIOLOGY
- Keywords
- Mycobacterium avium complex; ethambutol; rifampin; MIC; outcome
- Citation
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, v.66, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Volume
- 66
- Number
- 4
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/96897
- DOI
- 10.1128/aac.02027-21
- ISSN
- 0066-4804
1098-6596
- Abstract
- We evaluated the associations between the in vitro activities of ethambutol and rifampin and clinical outcomes of Mycobacterium avium complex (MAC) pulmonary disease (PD). Among 158 patients with MAC-PD, there was no relationship between high MICs for ethambutol and/or rifampin and treatment failure for MAC-PD. Ethambutol and rifampin resistance was common among MAC isolates (rates of 87% and 59%, respectively), but mutations in embB, rpoB, and rpoC were rare, with detection in only 4% of the drug-resistant MAC isolates.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/96897)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.